mRNA vaccine delivery using lipid nanoparticles

mRNA vaccines elicit a potent immune response including antibodies and cytotoxic T cells. mRNA vaccines are currently evaluated in clinical trials for cancer immunotherapy applications, but also have great potential as prophylactic vaccines. Efficient delivery of mRNA vaccines will be key for their...

Full description

Bibliographic Details
Main Authors: Reichmuth, Andreas Michael, Oberli, Matthias, Jaklenec, Ana, Langer, Robert S, Blankschtein, Daniel
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: Future Science, LTD 2017
Online Access:http://hdl.handle.net/1721.1/110919
https://orcid.org/0000-0003-4255-0492
https://orcid.org/0000-0002-7836-415X